BRIEF published on 04/07/2026 at 18:05, 29 days 14 hours ago Oxurion postpones its Annual General Meeting Pharmaceutical Digital Assets General Assembly Report Oxurion
BRIEF published on 04/07/2026 at 18:05, 29 days 14 hours ago Oxurion reporte son assemblée générale annuelle des actionnaires Calendrier Financier Assemblée Générale Des Actionnaires Risques D'investissement Oxurion Externalisation Pharmaceutique
PRESS RELEASE published on 04/07/2026 at 18:00, 29 days 14 hours ago Uitstel Gewone Algemene Vergadering Oxurion NV kondigt uitstel van de Jaarlijkse Vergadering van Aandeelhouders aan vanwege niet gefinaliseerde jaarrekening. Het bedrijf specialiseert zich in farmaceutische onderaannemers. Gevestigd in Leuven, België Oxurion NV Leuven Uitstel Jaarlijkse Vergadering Farmaceutisch
PRESS RELEASE published on 04/07/2026 at 18:00, 29 days 14 hours ago Postponement Annual Shareholders Meeting Oxurion NV postpones Annual Shareholders Meeting to June 1st, 2026 due to pending annual accounts. The pharmaceutical outsourcing company specializes in acquiring European subcontractors. Forward-looking statements in press release Forward-looking Statements Postponement Oxurion NV Pharmaceutical Outsourcing European Subcontractors
BRIEF published on 03/19/2026 at 18:35, 1 month 18 days ago Oxurion projette l'acquisition d'une CRO internationale Acquisition Stratégie De Croissance Développement Clinique Oxurion CRO Internationale
BRIEF published on 03/19/2026 at 18:35, 1 month 18 days ago Oxurion Announces Intent to Acquire International CRO Acquisition Clinical Research Pharmaceutical International Expansion Oxurion
BRIEF published on 03/19/2026 at 18:35, 1 month 18 days ago Oxurion annonce son intention d'acquérir une CRO internationale Acquisition Expansion Internationale Recherche Clinique Pharmaceutique Oxurion
BRIEF published on 03/19/2026 at 18:35, 1 month 18 days ago Oxurion plans to acquire an international CRO Growth Strategy Acquisition Clinical Development Oxurion International CRO
PRESS RELEASE published on 03/19/2026 at 18:30, 1 month 18 days ago Oxurion signs a letter of intent for the acquisition of an international CRO Oxurion NV (Euronext Brussels: OXUR) announces the signing of a letter of intent for acquiring an international CRO, strengthening its clinical development strategy Acquisition Clinical Development Euronext Brussels CRO Oxurion NV
PRESS RELEASE published on 03/19/2026 at 18:30, 1 month 18 days ago Oxurion ondertekent een intentieverklaring voor de overname van een internationale CRO. Oxurion NV plant die Übernahme eines Mehrheitsanteils an einer internationalen CRO, um ihr integriertes klinisches Entwicklungsmodell zu stärken Übernahme Oxurion NV Mehrheitsanteil Klinische Entwicklung Internationale CRO
Published on 05/07/2026 at 05:40, 2 hours 25 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 6 hours 5 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 8 hours 35 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 9 hours ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 9 hours 5 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 07:55, 9 minutes ago Leifheit AG publishes Q1 2026 results and is consistently implementing its Group strategy
Published on 05/07/2026 at 07:35, 30 minutes ago Rare Watches Spark Frenzied Interest in FutureGrail's May Auction
Published on 05/07/2026 at 07:35, 30 minutes ago Lenzing delivers positive net result in Q1 2026 and significantly increases free cash flow
Published on 05/07/2026 at 07:31, 33 minutes ago Henkel delivers good organic sales growth in the first quarter of 2026
Published on 05/07/2026 at 07:30, 34 minutes ago Q1 2026: Solid start to the year confirms transformation strategy
Published on 05/06/2026 at 18:00, 14 hours 5 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 14 hours 5 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 14 hours 5 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
